Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
prolonging spray.
Popular Articles

Depression May Increase Risk Of Alzheimer's Disease In People With Memory Problems
People with memory problems who are depressed are more likely to develop Alzheimer"s disease compared to people who are not depressed, according to a study published in the June 16, 2009, print issue of Neurology®, the medical journal of the American Academy of Neurology. However, the research also shows that the popular Alzheimer"s drug donepezil may delay the progression to Alzheimer"s disease for depressed people with mild cognitive impairment (MCI) or memory problems.
generic viagra
Rampant Disease Osteoporosis: Under-diagnosed, Under-treated - Experts Call For Earlier Diagnosis And Therapy
"With a continuously ageing population the incidence of osteoporosis is steadily rising. This does not only pose problems to the individuals concerned but is also an enormous challenge for our societies" according to Professor Wolfhart Puhl, past president of the European Federation of National Associations of Orthopaedics and Traumatology (EFORT). Prof. Puhl, of the Orthopç¤dikum Allgç¤u, Germany, who is in Vienna for the EFORT Congress, emphasized that the problem"s "dimension is frequently underestimated. Policy makers and funding agencies do not always consider this development sufficiently in their planning."
Zubni implantati
News of the day
FDA Approves VYVANSE CII Label Change To Include Supplementary Clinical Data Supporting Efficacy At 13 Hours Postdose In Children Age 6-12 With ADHD
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) has approved a change to the prescribing information for its once-daily Attention Deficit Hyperactivity Disorder (ADHD) treatment VYVANSE® (lisdexamfetamine dimesylate) CII, to include supplemental data that demonstrated significant ADHD symptom control in children aged 6 to 12 from the first time point measured (1.5 hours) through 13 hours postdose. VYVANSE is now the first and only oral ADHD stimulant treatment to have 13-hour postdose efficacy data for pediatric patients included in its product labeling.
Diagnostics

Gates Foundation Donates Additional $80M To Indian HIV-Prevention Program, Receives Indira Gandhi Prize For Peace, Disarmament And Development

The Bill & Melinda Gates Foundation will give an additional $80 million to Avahan, a foundation initiative launched in 2003 for HIV prevention programs in India, Bill Gates said on Thursday, the Seattle Times blog, "Business of Giving" reports. Previous foundation commitments to the program, "which involves more than 100 non-profits in six Indian states," total $258 million, the blog writes (Heim, 7/23). According to the Times of India, Gates and Indian Health Minister Ghulam Nabi Azad "will discuss gradual transition of Avahan to the government. Avahan has already awarded more than $100 million in grants for this transition." Gates said, "It"s not that the foundation is leaving India. The amount we spend in India on health and development will actually go up but will focus on other things like nutrition, maternal and child health and vaccines," the Times of India reports (Sinha, 7/24). The Telegraph reports that the Foundation plans to support other health issues, including vaccines to prevent pneumonia and viral diarrhea and drugs to treat visceral leishmaniasis, said Gates, who is in India to receive the Indira Gandhi Prize for Peace, Disarmament and Development on behalf of the foundation. According to the Telegraph, "Avahan-supported programmes have reached an estimated 220,000 commercial sex workers, 80,000 gays and about 5 million men at risk of becoming infected with HIV" (7/23). Gates, who received the peace prize on Saturday, said, "The Indian government must accelerate its progress toward its health spending targets, so that innovations benefit the poor people who really need them," the International Business Times reports. He also reiterated the foundation"s long-term commitment to helping India deal with a variety of health issues, saying, "India bears a massive burden of disease. But in the next five years, it can make more progress on health than it has made in any other five-year-period in its history" (7/26). The Seattle Times reports that "Avahan has begun handing over the reins to the government-run National AIDS Control Organisation [NACO]. During the transition, "Avahan will provide financial and technical support to ensure that prevention programs can be sustained over time,"" according to the foundation (7/23). In a written statement, K. Sujatha Rao, Secretary and Director General of NACO said, "Our collaboration with Avahan has made it possible to reach far more people with proven HIV prevention interventions. This strong partnership will continue as key aspects of Avahan transition to the government in the coming years" (Gates Foundation release, 7/23) While in India, Gates also met with the state of Bihar"s chief minister, Nitish Kumar, via video conference about polio and visceral leishmaniasis eradication efforts in the area, the Hindu reports (Banerjee, 7/25). Gates told Kumar, "We are ready to work with your government and all partners in the polio effort to stop transmission in Bihar and ultimately assure all parents that their children are safe from this crippling disease," the Bihar Times reports (7/24). This information was reprinted from globalhealth.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Global Health Policy Report, search the archives and sign up for email delivery at globalhealth.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009